Skip to main content
Clinical Trials/IRCT20150902023864N3
IRCT20150902023864N3RecruitingPhase 3

Comparison of the therapeutic effect of 5% ibuprofen nanoemulsion gel and commercial ibuprofen gel on knee osteoarthritis pain

Tehran University of Medical Sciences0 sites124 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
124

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Unilateral or bilateral knee osteoarthritis with radiographic evidence according to American College of Rheumatology criteria and the International Osteoarthritis Research Society which is diagnosed through physical examination by the physician
  • Having mild to moderate knee osteoarthritis pain
  • Written informed consent to participate in the study

Exclusion Criteria

  • Very severe knee pain
  • Recent lower limb injury or surgery such as repair and joint replacement
  • Inflammatory arthritis
  • Metabolic bone disease
  • Fracture and/or dislocation of knee
  • History of an open wound in the affected knee
  • History of adverse reactions to NSAIDs
  • Diabetes and Lupus disease
  • Corticosteroid injection into the knee within 30 days of intervention
  • Multiple sclerosis (MS)
  • The dermatologic disorder which affected the surrounding skin of the knees
  • Uncontrolled heart failure
  • High blood pressure
  • Chronic renal failure
  • Respiratory diseases
  • History of alcohol or drug abuse
  • History of neurological disorders affecting sensory, motor or cognitive function

Investigators

Similar Trials

Effect of Ibuprofen Nanoemulsion Gel on... | Clinical Trial